{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T04:56:06Z","timestamp":1698382566446},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":6202,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1992,5]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Natural killer (NK) cells were analyzed in 38 untreated patients with refractory anaemia with excess of blasts (RAEB), using cytotoxicity assays and immunofluorescence with monoclonal antibodies. We found that patients with RAEB have normal numbers of peripheral blood and bone marrow NK cells. NK cells from RAEB patients express very low natural\u2010killer cell activity (NKa) which may be increased significantly with recombinant a\u2010interferon and recombinant interleukin\u20102, although it remains below the lower limit of the control range. The cells exhibit normal tumour cell binding capacity, but fail to release sufficient amounts of natural\u2010killer cytotoxic factors (NKCFs) upon their interaction with NK\u2010sensitive K562 cell targets or their stimulation with phytohaemagglutinin. Our results suggest that defective NKa in RAEB patients may be due, at least in part, to impaired release of functionally active NKCFs. This disturbance is probably the result of some intrinsic defect of RAEB NK cells in NKCF production, storage, and\/or release. The possibility of an impairment in the activation signal provided by the stimulatory K562 cells cannot be excluded, although it seems unlikely. We postulate that this abnormality might represent a manifestation of dysplastic haemopoiesis. Further studies are certainly needed to investigate whether other defective mechanisms are also implicated in the determination of the low NKa in patients with RAEB.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1992.tb01800.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T11:57:23Z","timestamp":1279454243000},"page":"237-243","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms accounting for the impaired natural\u2010killer cell activity in refractory anaemia with excess of blasts"],"prefix":"10.1111","volume":"48","author":[{"given":"G. D.","family":"Eliopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Coulocheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Eliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Katrinakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Karkavitsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vaiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Foudoulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"359","article-title":"Les anemies refractaires avec exces de myeloblastes dans la moelle","volume":"78","author":"Dreyfus B.","year":"1970","journal-title":"Nouv Pres Med"},{"key":"e_1_2_1_3_2","first-page":"596","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"61","author":"Bennett JM","year":"1982","journal-title":"Br J Haematol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood.V61.6.1035.1035","article-title":"The smouldering myeloid leukemic states: clinical and biologic features","volume":"61","author":"Greenberg PL.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.38.11.1201"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.V73.1.248.248","article-title":"Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin","volume":"73","author":"Janssen JWG","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-12-932"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1983.00097.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.38.8.908"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb07504.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830220104"},{"key":"e_1_2_1_12_2","first-page":"685","article-title":"Defective mitogen\u2010induced cellular cytotoxicity in myelodysplastic syndromes. Recovery after a\u2010interferon administration","volume":"11","author":"Eliopoulos G.","year":"1991","journal-title":"Anticancer Res"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320191"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb06060.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1986.tb01783.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1986.tb01790.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7025208"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1983.00153.x-i1"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(80)90133-7"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.127.6.2575","article-title":"Phe\u2010notypes of human natural killer cell populations detected with monoclonal antibodies","volume":"127","author":"Zarling JM","year":"1981","journal-title":"J Immunol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.131.4.1789"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.12.2421.2421"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.129.1.433","article-title":"Studies on the mechanism of natural killer (NK) cell\u2010mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK\u2010sensitive target cells (NKCF) during co\u2010culture of NK effector cells with NK target cells","volume":"129","author":"Wright S.","year":"1982","journal-title":"J Immunol"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.138.6.1791","article-title":"Studies on the mechanism of natural killer (NK) cell\u2010mediated cytotoxicity (CMC). VII. Functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor","volume":"138","author":"Wright S.","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_1_25_2","first-page":"107","article-title":"Target\u2010effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes","volume":"40","author":"Roder JC","year":"1980","journal-title":"Immunology"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(84)90147-4"},{"key":"e_1_2_1_27_2","first-page":"21","article-title":"Effect of recombinant a\u2010interferon administration on peripheral blood lymphocyte subpopulations and natural killer cell activity in patients with refractory anemia with excess of blasts","volume":"33","author":"Eliopoulos G.","year":"1991","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V75.7.1525.1525","article-title":"Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia","volume":"75","author":"Trentin L.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90088-9"},{"key":"e_1_2_1_30_2","first-page":"33","article-title":"Preleukaemic states","volume":"2","author":"Dreyfus B.","year":"1976","journal-title":"Blood Cells"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1992.tb01800.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1992.tb01800.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T17:13:47Z","timestamp":1698081227000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1992.tb01800.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["10.1111\/j.1600-0609.1992.tb01800.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1992.tb01800.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}